Enclomiphene vs TRT: which should I consider first?

Short answer: If you want to preserve fertility and you have suspected secondary hypogonadism (problem at the hypothalamus/pituitary), try a gonadotropin-stimulating approach such as enclomiphene (or the more commonly used clomiphene citrate) first. If you have primary testicular failure, are older, are not interested in future fertility, or need a reliably predictable return of testosterone levels/symptoms, testosterone replacement therapy (TRT) is usually the appropriate first choice.

Key points to help decide

• How they work

  • Enclomiphene / clomiphene (SERMs): boost your own LH/FSH so the testes make more testosterone; because the testes keep working, spermatogenesis is generally preserved or improved.
  • TRT (exogenous testosterone): raises serum T directly but suppresses LH/FSH and commonly suppresses sperm production and testicular size.

• Who is a good candidate for each

  • Consider enclomiphene/clomiphene first if:
    • You’re younger and want to preserve or improve fertility.
    • Labs suggest secondary hypogonadism (low T with low/normal LH/FSH).
    • You prefer stimulating endogenous production rather than giving hormones.
  • Consider TRT first if:
    • You have primary hypogonadism (low T with high LH/FSH) or testicular failure.
    • You’re older and not interested in fertility.
    • You need predictable symptom relief and have failed or cannot use stimulating therapy.

• Efficacy, timeline and monitoring

  • Enclomiphene/clomiphene: may take weeks to months to raise T and improve symptoms; monitor morning total T, LH/FSH, and semen if fertility is a concern. Trial often 3–6 months.
  • TRT: tends to relieve symptoms faster and predictably increases serum T, but requires regular monitoring of hematocrit, PSA, lipids and periodic testosterone levels; sperm counts usually decline.

• Risks / side effects

  • Enclomiphene/clomiphene: mood changes, visual disturbances (rare), increased estradiol in some men; generally preserves fertility.
  • TRT: erythrocytosis, acne, sleep apnea worsening, testicular atrophy, reduced fertility; possible cardiovascular and prostate considerations—monitor closely.

• Availability and practical considerations

  • Enclomiphene (Androxal) has been studied clinically but availability varies by country and it has been less widely marketed than clomiphene. Many clinicians use clomiphene citrate (brand names Clomid, Serophene) off-label for men because it’s widely available and inexpensive.
  • TRT options (examples): AndroGel (topical gel), Testim (gel), Depo-Testosterone (testosterone cypionate injections), Testopel (subcutaneous pellets) — choice depends on cost, convenience and side-effect profile. Generic injectable testosterone (cypionate/enanthate) tends to be lower cost and effective.

Recommended next steps

1. Get proper testing first: two early-morning total testosterone measurements, LH, FSH, prolactin, SHBG (and semen analysis if fertility is important).
2. Discuss results with an endocrinologist or urologist (reproductive urologist if fertility is a priority).
3. If appropriate, consider a trial of enclomiphene/clomiphene for several months if you meet criteria and want fertility preserved; if that fails or is inappropriate, start TRT and set up appropriate monitoring.

If you want help finding care: endocrinology or male-reproductive urology at a major center (e.g., Mayo Clinic, Cleveland Clinic) is ideal. For easier access you can consider reputable telehealth men’s-health services such as Hims or Roman for initial evaluation and prescription — but for fertility questions or complicated cases, request referral to an in-person specialist.

If you want, tell me your age, fertility plans, and any lab results (testosterone, LH/FSH) and I can give more tailored guidance.